The U.S. Embassy in New Delhi has taken decisive action against certain Indian business executives and corporate leaders by revoking or denying their visas. This move comes in response to their alleged involvement in trafficking fentanyl precursors, as confirmed by the embassy in an official statement released on Thursday. Fentanyl precursors are the essential chemicals used in the production of fentanyl, a potent synthetic opioid responsible for a significant public health crisis in the United States. The embassy did not disclose the identities of the individuals affected by this visa action, maintaining confidentiality in line with its protocols. This development underscores the U.S. government’s intensified efforts to combat the global fentanyl trade and its supply chain. The decision also highlights the growing scrutiny of international business leaders linked to activities that contribute to the opioid epidemic. The embassy’s statement serves as a stern reminder of the legal and diplomatic consequences for those involved in such illicit activities.